Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage i non-small-cell lung cancer in elderly patients: Is less more?

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 4, 2013, Pages 476-482

  Alexander, Erica S ^a   Machan, Jason T ^a,c,d   Ng, Thomas ^a   Breen, Lucas D ^a   Dipetrillo, Thomas A ^b   Dupuy, Damian E ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANALYTICAL ERROR; ARTICLE; BILLING AND CLAIMS; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHI SQUARE TEST; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; FEMALE; GERIATRIC PATIENT; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MEDICARE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANK SUM TEST; REIMBURSEMENT; STATISTICAL SIGNIFICANCE; THORACOTOMY; WEDGE RESECTION;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; COST-BENEFIT ANALYSIS; FEMALE; HEALTH SERVICES FOR THE AGED; HOSPITAL COSTS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MEDICARE; MODELS, ECONOMIC; NEOPLASM STAGING; PNEUMONECTOMY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84875269566     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2012.12.016     Document Type: Article

References (27)

1. American Cancer Society. Cancer facts and figures 2010. Atlanta: American Cancer Society, 2010.
2. A. Jemal, L.X. Clegg, and E. Ward Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival Cancer 101 2004 3 27
3. M.L. Brown, G.F. Riley, N. Schussler, and R. Etzioni Estimating health care costs related to cancer treatment from SEER Medicare data Med Care 40 8 suppl 2002 IV-104-IV-117
4. American Lung Association. The future of lung health, 2005. Available at: http://www.lung.org/assets/documents/ALA-ANNUAL-REPORT-2005.pdf. Accessed April 18, 2006.
5. R.M. Woodward, M.L. Brown, S.T. Stewart, K.A. Cronin, and D.M. Cutler The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF Cancer 110 2007 2511 2518
6. A. Zemlyak, W.H. Moore, and T.V. Bilfinger Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer J Am Coll Surg 211 2010 68 72
7. A. Pennathur, G. Abbas, and W.E. Gooding Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service Ann Thorac Surg 88 2009 1601 1608
8. M. Lanuti, A. Sharma, and S.R. Digumarthy Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer J Thorac Cardiovasc Surg 137 2009 160 166
9. C.J. Simon, D.E. Dupuy, and T.A. DiPetrillo Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients Radiology 243 2007 268 275
10. de T. Baere, J. Palussiere, and A. Auperin Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation Radiology 240 2006 587 596
11. R. Lencioni, L. Crocetti, and R. Cioni Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study) Lancet Oncol 9 2008 621 628
12. S.R. Kim, H.J. Han, and A.J. Park Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer Eur J Radiol 81 2012 395 399
13. J.P. Wisnivesky, M. Bonomi, C. Henschke, M. Iannuzzi, and T. McGinn Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer Chest 128 2005 1461 1467
14. F.M. Kong, R.K. Ten Haken, and M.J. Schipper High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study Int J Radiat Oncol Biol Phys 63 2005 324 333
15. S. Sura, E. Yorke, A. Jackson, and K.E. Rosenzweig High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer Cancer J 13 2007 238 242
16. J.A. Bogart, L. Hodgson, and S.L. Seagren Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904 J Clin Oncol 28 2010 202 206
17. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 7 suppl 3 2007 S94 S100
18. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for medically inoperable early-stage lung cancer patients: analysis of RTOG 0236 Int J Radiat Oncol Biol Phys 75 suppl 2009 S3
19. R.J. Landreneau, D.J. Sugarbaker, and M.J. Mack Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer J Thorac Cardiovasc Surg 113 1997 691 698
20. N.S. Gandhi, and D.E. Dupuy Image-guided radiofrequency ablation as a new treatment option for patients with lung cancer Semin Roentgenol 40 2005 171 181
21. D.E. Dupuy, T. DiPetrillo, and S. Gandhi Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer Chest 129 2006 738 745
22. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
23. P.A. Kupelian, R. Komaki, and P. Allen Prognostic factors in the treatment of node-negative non-small cell lung carcinoma with radiotherapy alone Int J Radiat Oncol Biol Phys 36 1996 607 613
24. M.C. Ambrogi, O. Fanucchi, and R. Cioni Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study J Thorac Oncol 6 2011 2044 2051
25. R.M. Klevens, J.R. Edwards, and C.L. Richards Estimating healthcare-associated infections and deaths in U.S. hospitals, 2002 Public Health Rep 122 2007 160 166
26. S. Guterman, K. Davis, K. Stremikis, and H. Drake Innovation in Medicare and Medicaid will be central to health reform's success Health Aff 29 2010 188 193
27. D.M. Cutler, K. Davis, and K. Stremikis The impact of health reform on health system spending 2010 Center for American Progress Washington, DC